Biosimilars: Latin America´s Coming On Board: Regulatory Approval and Market Access
Biotechnological medicines are medicinal products of biotechnological origin that contain proteins derived
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Biotechnological medicines are medicinal products of biotechnological origin that contain proteins derived
regulatory requirements and characterization. Azaya has developed a battery of tests to support the regulatory approval pathway including a novel in vitro release method applicable to liposomal nanoparticles. This…
Obtaining Regulatory approvals for pharmaceutical products in MENA region is an essential requirement to market and sell pharmaceutical products in the fast growing market of the Middle East and North ... details, a…
same safety and efficacy profile. The EMA has taken the lead in the regulatory approval framework for biosimilar products, and WHO has published guidelines on the evaluation of biosimilars ... order to facilitate the…
small molecule generics, namely Menotropins (January 1997) and Enoxaparin (July 2010). Approval processes: The European regulatory authorities led with a specially adapted approval procedure to authorize subsequent…
biosimilar. Given the relatively small number/size of clinical trials required for regulatory approval of biosimilars, full characterization of the immunogenicity profile of a biosimilar may not be established ... time…
predict toxicities as early as possible. Could regulatory agencies adopt toxicogenomics screening as a faster and cost saving technique when approving herbal products in this region? Are there advantages ... knowledge…
regulatory landscape and expectations of multiple stakeholders have increased the complexity, unpredictability and intensity of the biopharmaceutical product development and registration process. Activities…
N-glycosylation is one of the important post-translational modifications of therapeutic
Biotechnological medicines are medicinal products of biotechnological origin that contain proteins derived
Since human cells and tissue products belong to a relatively new class
constrain of Regulatory Affairs reveals diverse countries need to follow different regulatory requirements for Marketing Authorization Application (MAA) approval of new drugs. Every country has its own regulatory…
treatments. However, the approval and regulation of ATMPs present unique challenges due to their complexity, variability, and the novel technologies involved. This article examines the regulatory hurdles faced by ATMPs…
This article examines the critical role of integrating toxicology in approval processes within the regulatory landscape. As regulatory agencies worldwide strive to ensure consumer safety and environmental protection…
better medicine is going on. In this scenario, the timeliness with which national regulatory agencies approve new drugs for marketing affects health care professionals and patients significantly. As an unnecessarily
years Brazil has taken some actions to improve the timeline and quality for regulatory approvals in clinical trials. The Local Health AuthorityâÂ?Â?ANVISA issue 2 new regulations for this
Competition and Innovation Act of 2009 (BPCI Act) in US established a regulatory pathway for the approval and marketing of biosimilars in US. FDA subsequently published a number of general ... provide guidelines to the…
years Brazil has taken some actions to improve the timeline and quality for regulatory approvals in clinical trials. The Local Health Authority – ANVISA issue 2 new regulations for this process
article explores the stages of drug development, including discovery, preclinical testing, clinical trials, and regulatory approval. It discusses the challenges and innovations in the field, emphasizing the importance…
have been shown to have comparable quality, safety, and efficacy to the innovator products. Regulatory approval for a biosimilar version is provided on the basis of its comparability ... summary, the paradigm shift in…
interventions, including drugs, vaccines, and devices. They are essential for evidence-based medicine, informing regulatory approvals, clinical guidelines, and patient care. This article discusses the types, design…
therapeutics for human use. It encompasses stages from initial discovery, preclinical studies, clinical trials, regulatory approval, and post-marketing surveillance. This article provides an overview of the drug…
For authors and organisers
Find the right journal for your paper and submit your manuscript.